elevate bpc 157 BPC-157 FDA Approval Status: Is It Approved for Human Use? Is Joe Rogan Right About
Description
15 , R42 (2013)
This is based on its ability to counteract ketamine and MK-801, NMDA receptor antagonists that model negative-like schizophrenia symptoms in rodents
10.1056/NEJMoa1809983 [DOI] [PubMed] [Google Scholar] 257.Tabi T, Vecsei L, Youdim MB, Riederer P, Szoko E
10 The committee selected three of those eight for in-depth exploration based on the objectives of covering especially plausible futures and of exploring scenarios that resulted in the most challenges and opportunities for the Intelligence Community
